Phorbiplatin, a Highly Potent Pt(IV) Antitumor Prodrug That Can Be Controllably Activated by Red Light
- 1 December 2019
- journal article
- research article
- Published by Elsevier BV in Chem
- Vol. 5 (12), 3151-3165
- https://doi.org/10.1016/j.chempr.2019.08.021
Abstract
No abstract availableKeywords
Funding Information
- Hong Kong Research Grants Council (CityU 11304318, 11307419)
- National Natural Science Foundation of China (21877092)
- City University of Hong Kong (9610369, 9667148)
- Science Technology and Innovation Committee of Shenzhen Municipality (JCYJ20170307091106444)
- Shenzhen University (2018022)
This publication has 75 references indexed in Scilit:
- Novel tetracarboxylatoplatinum(iv) complexes as carboplatin prodrugsDalton Transactions, 2012
- Platinum resistance in breast and ovarian cancer cell linesJournal of Experimental & Clinical Cancer Research, 2011
- Synthesis, Characterization, and Cytotoxicity of Platinum(IV) Carbamate ComplexesInorganic Chemistry, 2011
- Quenching Enhancement of the Singlet Excited State of Pheophorbide‐a by DNA in the Presence of the Quinone CarboquonePhotochemistry and Photobiology, 2010
- A potent cytotoxic photoactivated platinum complexProceedings of the National Academy of Sciences of the United States of America, 2007
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- Molecular mechanisms of resistance and toxicity associated with platinating agentsCancer Treatment Reviews, 2007
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- Nucleotide Cross‐Linking Induced by Photoreactions of Platinum(IV)–Azide ComplexesAngewandte Chemie, 2003
- A FLASH PHOTOLYSIS STUDY OF INTERMEDIATES IN PHOTOCHEMICAL REACTIONS OF CHLOROPHYLLPhotochemistry and Photobiology, 1969